Sale!

SMAD6 Gene Aortic Valve Disease Type 2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “SMAD6 Gene Aortic Valve Disease Type 2 Genetic Test” is a specialized diagnostic tool designed to identify mutations in the SMAD6 gene, which are associated with Aortic Valve Disease Type 2 (AVD2). This condition is a critical cardiovascular anomaly that affects the structure and function of the aortic valve, potentially leading to heart failure and other serious complications if left undiagnosed and untreated.

The test involves analyzing the patient’s DNA to detect any genetic variations in the SMAD6 gene that could predispose them to AVD2. Early detection through this genetic testing is crucial for the management and treatment of the condition, allowing healthcare providers to implement preventative measures or interventions to mitigate the risk of severe outcomes.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis ensuring accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to conduct this specialized genetic assessment.

By opting for the SMAD6 Gene Aortic Valve Disease Type 2 Genetic Test, individuals at risk can take a proactive step towards understanding their genetic predisposition to AVD2, enabling informed decisions about their health and future medical care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SMAD6 Gene Aortic Valve Disease Type 2 Genetic Test

At DNA Labs UAE, we offer the SMAD6 Gene Aortic Valve Disease Type 2 Genetic Test for AED 4400.0.

Test Details

The SMAD6 gene is associated with aortic valve disease type 2, a condition that affects the valve between the left ventricle and the aorta. This valve is responsible for carrying oxygenated blood from the heart to the rest of the body.

Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, identifying variations or mutations that may be associated with aortic valve disease type 2. By understanding these genetic variations, healthcare professionals can provide more personalized and targeted treatment options for affected individuals.

In addition to treatment options, NGS genetic testing can also assist with genetic counseling, providing information about the risk of passing the condition on to future generations.

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Vascular Diseases
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Before undergoing the SMAD6 Gene Aortic Valve Disease Type 2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. A genetic counseling session may also be conducted to draw a pedigree chart of family members affected by SMAD6 Gene Aortic Valve Disease Type 2.

For more information or to schedule a test, please contact our genetics department.

Test Name SMAD6 Gene Aortic valve disease type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Vascular Diseases
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SMAD6 Gene Aortic valve disease type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMAD6 Gene Aortic valve disease type 2 NGS Genetic DNA Test gene SMAD6
Test Details

The SMAD6 gene is associated with aortic valve disease type 2. Aortic valve disease is a condition that affects the valve between the left ventricle and the aorta, which is the main artery that carries oxygenated blood from the heart to the rest of the body.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify variations or mutations that may be associated with a particular condition or disease. In the case of aortic valve disease type 2, NGS genetic testing can be used to identify variations or mutations in the SMAD6 gene that may be contributing to the development of the disease.

By identifying these genetic variations, healthcare professionals can better understand the underlying cause of aortic valve disease type 2 and provide more personalized and targeted treatment options for affected individuals. Additionally, NGS genetic testing can also help with genetic counseling and provide information about the risk of passing the condition on to future generations.